Sun Pharma secures CDSCO panel okay for Amantadine ER Tablets to treat Parkinson Medical Dialogues Team30 July 2021 12:35 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Withdraw marketing of Durvalumab for metastatic urothelial carcinoma: CDSCO panel tells AstraZeneca Medical Dialogues Team27 July 2021 5:43 PM ISTNew Delhi: In a major setback to AstraZeneca Pharma India Limited., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Include more Govt sites in Dapagliflozin, Teneligliptin FDC phase 3 trial: CDSCO panel tells Macleods Pharma Medical Dialogues Team25 July 2021 11:15 AM ISTNew Delhi: Macleods Pharmaceutical has recently received permission from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Sun Pharma cancer drug Pemetrexed Solution for Infusion gets CDSCO panel okay Medical Dialogues Team23 July 2021 6:23 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Sun Pharma gets CDSCO panel nod for Tetracosactide injection Medical Dialogues Team21 July 2021 4:06 PM ISTNew Delhi: Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Cadila Healthcare gets CDSCO panel okay for Fluticasone Furoate, Oxymetazoline HCL nasal spray Medical Dialogues Team19 July 2021 1:00 PM ISTNew Delhi: In a major rejoice for pharma major Cadila Healthcare, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Glenmark gets CDSCO panel marketing nod to Remogliflozin, Teneligliptin FDC Medical Dialogues Team18 July 2021 11:30 AM ISTNew Delhi: In a major rejoice to Mumbai-based Glenmark Pharmaceuticals Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard...
Serum Institute gets CDSCO panel nod to conduct clinical trial of Reduced Inactivated Salk Polio Vaccine Medical Dialogues Team13 July 2021 10:15 AM ISTNew Delhi: Vaccine maker Serum Institute of India (SII) has recently got approval from the Subject Expert Committee (SEC) of the Central Drugs...
GSK gets CDSCO panel okay for marketing Inactivated Influenza Vaccine for those above 64 Medical Dialogues Team12 July 2021 4:54 PM ISTNew Delhi: Granting the permission of local clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Revise phase 3 clinical trial protocol for Tapentadol Nasal Spray: CDSCO panel tells Torrent Pharma Medical Dialogues Team12 July 2021 11:20 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Organization (CDSCO) has directed Torrent Pharmaceuticals to...
Abbott gets CDSCO panel nod for importing, marketing of Estradiol, Dydrogesterone FDC Medical Dialogues Team11 July 2021 10:30 AM ISTNew Delhi: Approving Phase III Clinical Trial (CT) waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Sun Pharma secures CDSCO Panel nod to conduct phase IV Trial of Atropine Sulfate Ophthalmic Solution Medical Dialogues Team9 July 2021 6:17 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has recently secured permission from the Subject Expert Committee (SEC) of the Central Drugs Standard...
